. Author manuscript; available in PMC: 2021 Jul 7.

Published in final edited form as: J Clin Hypertens (Greenwich). 2021 May 4;23(6):1165–1175. doi: 10.1111/jch.14245

TABLE 2.

Procedural and post-procedural data

	N = 94
Transfemoral approach	94 (100)
Balloon expandable TAVR	94 (100)
Echocardiographic data at discharge
Mean gradient (mm Hg)	10.5 ± 3.8
AVA index (cm²/m²)	1.1 ± 2.7
LVEF (%)	60 (55–60)
Paravalvular aortic regurgitation ≥II	3 (3.2)
In-hospital complications
Myocardial infarction	1 (1.1)
Stroke or TIA	1 (1.1)
Minor vascular complication (VARC-2)	4 (4.2)
Major vascular complication (VARC-2)	0
Bleeding complication (BARC ≤ II)	9 (9.5)
Bleeding complication (BARC > II)	0
New-onset atrial fibrillation	1 (1.1)
New definitive pacemaker	8 (8.5)
Death	0

Note: Values presented as mean ± SD, median (IQ range) or n (%).

Vascular complications are categorized according to the Valve Academic Research Consortium (VARC)-2. Bleeding complications are defined according to the Bleeding Academic Research Consortium (BARC).

Abbreviations: AVA, Aortic valve area; LVEF, Left ventricular ejection fraction; TAVR, Transcatheter aortic valve replacement; TIA, Transient ischemic attack.